ExodusPoint Capital Management, LP
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,931,128
+$2,438,515 QoQ
Shares Held
121,121
+10.9% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#68
of 193 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Derivatives in GLUE
reported options exposure · as of Dec 31, 2023CallValue
$630
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. GLUE ranks #30 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in GLUE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,931,128 | 121,121 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $492,613 | 109,227 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $447,040 | 96,345 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $2,086,005 | 393,586 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,149,373 | 307,319 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,870,209 | 265,278 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $630 | 100,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $1,298,392 | 229,804 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,966,197 | 619,248 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,586,040 | 669,495 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,037,809 | 261,593 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||